Selected Safety Information
- If follicular development occurs, atresia of the follicle is sometimes delayed, and the follicle may continue to grow beyond the size it would attain in a normal cycle. Generally, these enlarged follicles disappear spontaneously. Rarely, surgery may be required.
Removal of NEXPLANON
Before initiating the removal procedure, the health care provider should carefully read the instructions for removal and consult the USER CARD and/or the PATIENT CHART LABEL for the location of the implant. The exact location of the implant in the arm should be verified by palpation. If the implant is not palpable, two-dimensional x-ray can be performed to verify its presence.
A non-palpable implant should always be first located prior to removal. Suitable methods for localization include: two-dimensional x-ray, x-ray computerized tomography (CT), ultrasound scanning (USS) with a high-frequency linear array transducer (10 MHz or greater), or magnetic resonance imaging (MRI). If these imaging methods fail to locate the implant, etonogestrel blood level determination can be used for verification of the presence of the implant. For details on etonogestrel blood level determination, call 1-877-467-5266 for further instructions.
After localization of a non-palpable implant, consider conducting removal with ultrasound guidance.
There have been occasional reports of migration of the implant; usually this involves minor movement relative to the original position. This may complicate localization of the implant by palpation, CT, USS and/or MRI, and removal may require a larger incision and more time.
Exploratory surgery without knowledge of the exact location of the implant is strongly discouraged. Removal of deeply inserted implants should be conducted with caution in order to prevent injury to deeper neural or vascular structures in the arm and be performed by health care providers familiar with the anatomy of the arm.
Prior to removal
The woman does not have allergies to the antiseptic or anesthetic to be used
Equipment needed
The following equipment is needed for the removal of the implant:
An examination table for the woman to lie on
Sterile surgical drapes, sterile gloves, antiseptic solution, sterile marker (optional)
Local anesthetic, needles, and syringe
Sterile scalpel, forceps (straight and curved mosquito)
Skin closure, sterile gauze, adhesive bandage and pressure bandages
Removal procedure
Step 1.
Clean the site where the incision will be made and apply an antiseptic. Locate the implant by palpation and mark the distal end (end closest to the elbow), for example, with a sterile marker (Figure 1).Step 2.
Anesthetize the arm, for example, with 0.5 to 1 mL 1% lidocaine at the marked site where the incision will be made (Figure 2). Be sure to inject the local anesthetic under the implant to keep it close to the skin surface.Step 3.
Push down the proximal end of the implant (Figure 3) to stabilize it; a bulge may appear indicating the distal end of the implant. Starting at the distal tip of the implant, make a longitudinal incision of 2 mm towards the elbow.Step 4.
Gently push the implant towards the incision until the tip is visible. Grasp the implant with forceps (preferably curved mosquito forceps) and gently remove the implant (Figure 4).Step 5.
Step 6.
If the tip of the implant does not become visible in the incision, gently insert a forceps into the incision (Figure 7). Flip the forceps over into your other hand (Figure 8).Step 7.
With a second pair of forceps carefully dissect the tissue around the implant and grasp the implant (Figure 9). The implant can then be removed.Step 8.
Step 9.
Step 10.
Replacing NEXPLANON (etonogestrel implant)
The new implant may be inserted in the same arm, and through the same incision from which the previous implant was removed. If the same incision is being used to insert a new implant, anesthetize the insertion site [for example, 2 mL of lidocaine (1%)] applying it just under the skin along the 'insertion canal.'
Follow the subsequent steps in the insertion procedure.
Selected Safety Information
About NEXPLANON (etonogestrel implant) 68 mg (continued)
- Some studies suggest that the use of combination hormonal contraceptives might increase the incidence of breast cancer, and increase the risk of cervical cancer or intraepithelial neoplasia. Women with a family history of breast cancer or who develop breast nodules should be carefully monitored.
- NEXPLANON should be removed if jaundice occurs.




